MRK vs TTD: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and The Trade Desk, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
VS
The Trade Desk, Inc. · Communication Services
$18.51
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
TTD has more upside to fair value
(+45.0%).
TTD trades at a lower forward P/E
(20.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
TTD |
| Current Price |
$113.87 |
$18.51 |
| Fair Value Estimate |
$100.14 |
$26.84 |
| Upside to Fair Value |
-12.1%
|
+45.0%
|
| Market Cap |
$281.2B |
$8.7B |
| Forward P/E |
32.0x
|
20.3x
|
| EV / EBITDA |
17.3x
|
10.5x
|
| Price / Sales |
4.3x
|
2.9x
|
| Price / FCF |
19.9x
|
10.4x
|
| Revenue Growth YoY |
+4.3%
|
+11.8%
|
| Gross Margin |
75.9%
|
77.8%
|
| Operating Margin |
27.6%
|
20.3%
|
| Return on Equity |
17.9%
|
16.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.02%
|
9.62%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
The Trade Desk operates a leading demand-side platform in the advertising technology sector, specializing in programmatic ad buying with a strong focus on connected TV, retail media, audio, and international markets. The company benefits from a durable competitive moat driven by founder-led management with over 15 years of continuity, a differentiated open-internet infrastructure, and a dominant …
Accumulation Zones
| Metric |
MRK |
TTD |
| Zone Low |
$75.11 |
$20.13 |
| Zone High |
$85.12 |
$22.81 |
| In Buy Zone? |
No
|
Yes
|